Ouyang et al., 2013 - Google Patents
Probing the RNA binding surface of the HIV-1 nucleocapsid protein by site-directed mutagenesisOuyang et al., 2013
- Document ID
- 17763601688919914888
- Author
- Ouyang W
- Okaine S
- McPike M
- Lin Y
- Borer P
- Publication year
- Publication venue
- Biochemistry
External Links
Snippet
The highly conserved nucleocapsid protein domain in HIV-1 recognizes and binds SL3 in genomic RNA. In this work, we used the structure of the NCp7–SL3 RNA complex to guide the construction of 16 NCp7 mutants to probe the RNA binding surface of the protein [De …
- 241000713772 Human immunodeficiency virus 1 0 title abstract description 222
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nathan et al. | Calcium ions directly interact with the Ebola virus fusion peptide to promote structure–function changes that enhance infection | |
Jones et al. | Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding | |
Chen | HIV capsid assembly, mechanism, and structure | |
Shubsda et al. | Affinities of packaging domain loops in HIV-1 RNA for the nucleocapsid protein | |
Santner et al. | Sweeping away protein aggregation with entropic bristles: intrinsically disordered protein fusions enhance soluble expression | |
Maroun et al. | Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers | |
Cohen et al. | The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation | |
Bocanegra et al. | Molecular recognition in the human immunodeficiency virus capsid and antiviral design | |
Ehrlich et al. | Partitioning of HIV-1 Gag and Gag-related proteins to membranes | |
JP4439261B2 (en) | Synthetic or natural peptides that bind to protein phosphatase 2A and methods and uses thereof | |
Kelly et al. | Implications for viral capsid assembly from crystal structures of HIV-1 Gag1-278 and CAN133-278 | |
Pak et al. | Off-pathway assembly: a broad-spectrum mechanism of action for drugs that undermine controlled HIV-1 viral capsid formation | |
Tsiang et al. | A trimer of dimers is the basic building block for human immunodeficiency virus-1 capsid assembly | |
Pandey et al. | The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration | |
JP2005522185A5 (en) | ||
Bosco et al. | Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs | |
Chertova et al. | Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide | |
Kopylov et al. | The maize (Zea mays L.) nucleoside diphosphate kinase1 (ZmNDPK1) gene encodes a human NM23-H2 homologue that binds and stabilizes G-quadruplex DNA | |
Park et al. | Binding of clinical inhibitors to a model precursor of a rationally selected multidrug resistant HIV-1 protease is significantly weaker than that to the released mature enzyme | |
Provitera et al. | Role of the major homology region in assembly of HIV-1 Gag | |
Pak et al. | Preservation of HIV-1 Gag helical bundle symmetry by bevirimat is central to maturation inhibition | |
Hodge et al. | Binding of c-Raf1 kinase to a conserved acidic sequence within the carboxyl-terminal region of the HIV-1 Nef protein | |
Ouyang et al. | Probing the RNA binding surface of the HIV-1 nucleocapsid protein by site-directed mutagenesis | |
Mitra et al. | The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function | |
Athavale et al. | Effects of the nature and concentration of salt on the interaction of the HIV-1 nucleocapsid protein with SL3 RNA |